NEHA VERMA
Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism MORRISTOWN, NJ NPI 1538569355
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism NJ Corcept Therapeutics All categories
General Payments — all program years on this page
$576.13
- Category: General Payments
- Program years: PY2019–2024
- Record count: 23
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $258.03 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $258.03 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Corcept Therapeutics | $81.48 | 2 |
| Medtronic, Inc. | $70.31 | 3 |
| DEXCOM, INC. | $67.90 | 1 |
| Novo Nordisk AS | $38.34 | 2 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1096602919 | Novo Nordisk Inc | $19.29 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1097581995 | Novo Nordisk Inc | $19.05 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117756767 | Corcept Therapeutics | $46.40 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117756775 | Corcept Therapeutics | $35.08 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1119367311 | Medtronic, Inc. | $25.60 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1119367313 | Medtronic, Inc. | $22.73 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1119367315 | Medtronic, Inc. | $21.98 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1153325207 | Dexcom, Inc. | $67.90 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.